Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Noriaki Tokuda is active.

Publication


Featured researches published by Noriaki Tokuda.


The Journal of Urology | 2004

Collecting Duct (Bellini Duct) Renal Cell Carcinoma: A Nationwide Survey in Japan

Noriaki Tokuda; Seiji Naito; Osamu Matsuzaki; Yoji Nagashima; Seiichiro Ozono; Tatsuo Igarashi

PURPOSE Collecting duct carcinoma, a rare type of renal cell carcinoma, remains poorly understood. To analyze the nature of collecting duct carcinoma a retrospective survey was performed in Japan. MATERIALS AND METHODS This survey was done from August 2001 to April 2003. A total of 281 institutions throughout Japan were requested to document all cases of collecting duct carcinoma. All pertinent clinical information was compiled, including patient age, sex, mode of presentation, evaluation modality, preoperative laboratory data, surgery type, macroscopic and microscopic findings, and survival data. Two urological pathologists reviewed microscopic slides of all tumor specimens to confirm collecting duct carcinoma. RESULTS Two pathologists confirmed collecting duct carcinoma in 81 of the 120 cases documented as collecting duct carcinoma. Mean patient age was 58.2 years and males comprised 71.6% of all patients. The mode of presentation was classified as symptomatic in 65.4% of cases, incidental in 24.7% and not available in 9.9%. Regional lymph node metastasis was histologically detected in 44.2% of patients who underwent lymph node dissection, while 32.1% of the population had distant metastasis at presentation. Although postoperative adjuvant therapy against metastasis or recurrence was performed in 25 patients, no obvious responses were identified except in 1 with lung metastases, who showed a partial response to combined gemcitabine and carboplatin therapy. At a median followup of 15 months 1, 3, 5 and 10-year disease specific survival was 69.0%, 45.3%, 34.3% and 13.7%, respectively. CONCLUSIONS We report what is to our knowledge the largest known series of collecting duct carcinoma. Since advanced or recurrent collecting duct carcinoma is resistant to standard treatment modalities, new treatment strategies are needed for advanced collecting duct carcinoma.


International Journal of Urology | 2011

Ureterosciatic hernia successfully treated by ureteral stent placement

Masaaki Sugimoto; Hidenori Iwai; Takeshi Kobayashi; Futoshi Morokuma; Takehiro Kanou; Noriaki Tokuda

A 76‐year‐old woman with history of cholecystectomy, hysterectomy, and vesicourethral suspension presented with acute lumbar backache and discomfort in the lower abdomen and severe nausea, with frequent vomiting, but without any associated fever. Physical examination revealed knocking tenderness at the left costal–vertebral angle. The patients serum white blood cell count was 14 900 /mm3 and the results of other laboratory tests, including urinalysis, were normal. Non‐enhanced computed tomography revealed left hydroureteronephrosis and obstruction of the distal left ureter with herniation into the sciatic foramen. A left ureteral stent was inserted with a double‐J stent. The stent was removed after 2 months and thereafter the patient did not experience any recurrence.


Clinical and Experimental Nephrology | 2003

Inhibition of gluconeogenesis and p-aminohipuric acid accumulation in rat renal cortical slices by ionic and nonionic contrast media.

Motonobu Nakamura; Jiro Uozumi; Kyoko Soejima; Takehiro Kanou; Noriaki Tokuda; Seiji Naito

AbstractBackground. Renal dysfunction is a well-recognized complication induced by contrast media (CM). Nonionic CM have been introduced into clinical use to replace conventional ionic CM in an effort to reduce toxicity. However, the nephrotoxic effects of nonionic CM have not been fully evaluated. We previously determined the activities of N-acetyl-β-d-glucosaminidase and γ-glutamyltransferase released from rat and human renal slices incubated with contrast media. Dose-dependent enzyme release from renal slices was observed, but there was no statistical difference in the increase of enzyme activities between ionic and nonionic CM. The present experiment was conducted to compare the effects of ionic and nonionic CM on the metabolic function of rat renal slices. Methods. Rat renal cortical slices were incubated with ionic CM (diatrizoate, iothalamate) and nonionic CM (iopamidol, iohexol) at 37°C for 90 min. To examine the dose–response effects of CM on gluconeogenesis and p-aminohipuric acid (PAH) accumulation in the rat renal slices, slices were incubated with 30, 60, and 90 mg I/ml of CM. The inhibitory effects of nonionic CM on gluconeogenesis and PAH accumulation were compared with those of ionic CM in an independent experiment, in which slices were incubated with CM at a concentration of 60 mg I/ml. In addition, rat renal slices were incubated with mannitol instead of CM to investigate the effects of osmotic pressure on gluconeogenesis and PAH accumulation. Results. A dose-dependent reduction of gluconeogenesis in rat renal slices was demonstrated by both ionic CM and nonionic CM. The inhibition of PAH accumulation was dose-dependent with nonionic CM, but not with ionic CM. Gluconeogenesis and PAH accumulation within the renal slices were both inhibited according to the increase in osmotic pressure produced by mannitol. The reduction in gluconeogenesis and PAH accumulation within the rat renal slices incubated with 60 mg I/ml of nonionic CM were significantly less than those resulting from the same concentration of ionic CM. Conclusions. Nonionic CM is less nephrotoxic than ionic CM with regard to gluconeogenesis and PAH accumulation in rat renal slices. These differences in nephrotoxic effect between ionic and nonionic CM may in part be attributable to differences in osmotic pressure.


Japanese Journal of Clinical Oncology | 2017

Predictive factors of late biochemical recurrence after radical prostatectomy

Takahito Negishi; Kentarou Kuroiwa; Yoshifumi Hori; Toshihisa Tomoda; Hiroshi Uchino; Noriaki Tokuda; Nobuki Furubayashi; Kei Nagase; Hidenori Iwai; Motonobu Nakamura

Objective To assess the characteristics of biochemical recurrence in the late period (>5 years after radical prostatectomy) and the differences in the predictors of biochemical recurrence in different periods, we conducted a multicenter retrospective study. Methods We reviewed 478 men who underwent radical prostatectomy for clinically localized prostate cancer. All of the patients were followed up for at least 5 years. The cohort was then divided into three groups; no recurrence group, recurrence <5 years after surgery group and recurrence ≥5 years after surgery group. The background characteristics of each group were compared using the χ2 test. A Cox multivariate regression analysis was performed to determine the predictors of biochemical recurrence in each period. Results Biochemical recurrence occurred in 135 men. In 113 (84%) of the patients, biochemical recurrence occurred at <5 years after surgery; in 22 (16%), it occurred at ≥5 years after surgery. The proportion of men with a low preoperative prostate-specific antigen level was significantly larger in the latter group (P = 0.0023). A preoperative prostate-specific antigen level and a positive surgical margin were significant predictors of biochemical recurrence at <5 years after surgery (hazard ratio: 1.03 and 3.20). A positive surgical margin was also a significant predictor of biochemical recurrence at ≥5 years after surgery (hazard ratio: 3.03); however, a high preoperative prostate-specific antigen level was not. Conclusions Biochemical recurrence occurred at ≥5 years after surgery in 16% of the patients. A positive surgical margin predicted biochemical recurrence in both the early and late periods.


Indian Journal of Urology | 2006

Villous adenoma of female urethra: An investigation of the mechanism of development regarding glandular neoplasms in the urinary tract

Masaki Shiota; Noriaki Tokuda; Takehiro Kanou; Humio Yamasaki

Villous adenomas are rare in the urinary tract. We herein report the fifth known such case while also making a review of the literature. A 54-year-old woman noticed a mass in her external genitalia and a tumor located on her external urethral orifice. The tumor was excised and pathologically confirmed to be a villous adenoma. Up to now, no sign of recurrence has been observed. However, we should be careful for malignant formation, because villous adenomas in the urinary tract frequently coexist with either adenocarcinoma or urothelial carcinoma.


Japanese Journal of Clinical Oncology | 2017

Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial

Masafumi Oyama; Takayuki Sugiyama; Masahiro Nozawa; Kiyohide Fujimoto; Takeshi Kishida; Go Kimura; Noriaki Tokuda; Shiro Hinotsu; Kojiro Shimozuma; Hideyuki Akaza; Seiichiro Ozono

The progression-free survival in Japanese was similar to that recorded in the RECORD-1 study, whereas prolongation of overall survival was observed in this study compared with the RECORD-1 study.


Japanese Journal of Clinical Oncology | 2004

Tumor doubling time of renal cell carcinoma measured by CT: Collaboration of Japanese Society of Renal Cancer

Seiichiro Ozono; Noriomi Miyao; Tatsuo Igarashi; Ken Marumo; Hayakazu Nakazawa; Momokuni Fukuda; Tomoyasu Tsushima; Noriaki Tokuda; Juichi Kawamura; Masaru Murai


Yonsei Medical Journal | 2007

Incidence Rate of Injection-Site Granulomas Resulting from the Administration of Luteinizing Hormone-Releasing Hormone Analogues for the Treatment of Prostatic Cancer

Masaki Shiota; Noriaki Tokuda; Takehiro Kanou; Humio Yamasaki


Journal of Nippon Medical School | 2007

Injection‑Site Granulomas Resulting from the Administration of Both Leuprorelin Acetate and Goserelin Acetate for the Treatment of Prostatic Cancer

Masaki Shiota; Noriaki Tokuda; Takehiro Kanou; Humio Yamasaki


International Journal of Clinical Oncology | 2013

Randomized controlled study of natural interferon α as adjuvant treatment for stage II or III renal cell carcinoma

Shiro Hinotsu; Koji Kawai; Seiichiro Ozono; Tomoyasu Tsushima; Noriaki Tokuda; Koichiro Nomata; Seiji Naito; Hideyuki Akaza

Collaboration


Dive into the Noriaki Tokuda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Go Kimura

Nippon Medical School

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Juichi Kawamura

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge